Fox 19: Feeling down while homebound? You are not alone
UC psychologist offers tips for beating the blues during COVID-19
Fox 19 journalist Courtney King discussed mental health and the coronavirus’ impact with Maria Espinola, PsyD, assistant professor at the University of Cincinnati College of Medicine. Espinola, a license psychologist seeing patients at UC Health, explained that isolation is a risk-factor for mental health issues and physical.
“We are just social animals, we need that connection,” Espinola told Fox 19.
Espinola says she’s seen an increase in cases of depression since the Stay-at-Home orders went into effect, while many of those who already had the diagnosis have seen their symptoms worsen. “And then people who never had these challenges are now finding themselves experiencing high levels of stress and oftentimes depression,” she said.
Espinola offered some recommendations such as sticking to a regular routine every day. That structure can help manage some of the symptoms of isolation. “That means waking up at the same time, going to bed at the same time,” she said. “Engaging in healthy lifestyle choices, what you’re eating, making sure you are exercising.”
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.